Analysts Offer Predictions for Spectral AI Q1 Earnings

Spectral AI, Inc. (NASDAQ:MDAI) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Spectral AI in a research note issued to investors on Thursday, August 14th. HC Wainwright analyst S. Ramakanth forecasts that the company will earn ($0.12) per share for the quarter. The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. HC Wainwright also issued estimates for Spectral AI’s Q2 2026 earnings at $0.10 EPS, Q3 2026 earnings at $0.12 EPS and Q4 2026 earnings at $0.12 EPS.

Separately, Wall Street Zen lowered shares of Spectral AI from a “hold” rating to a “strong sell” rating in a research note on Saturday.

Spectral AI Trading Up 0.5%

MDAI opened at $2.11 on Friday. Spectral AI has a 12-month low of $0.82 and a 12-month high of $3.25. The firm has a 50 day moving average of $2.42 and a two-hundred day moving average of $1.83. The firm has a market capitalization of $53.43 million, a PE ratio of -3.06 and a beta of 0.90.

Spectral AI (NASDAQ:MDAI) last released its earnings results on Tuesday, August 12th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.03). The company had revenue of $5.07 million during the quarter, compared to analysts’ expectations of $5.44 million.

Hedge Funds Weigh In On Spectral AI

Several institutional investors and hedge funds have recently modified their holdings of the stock. Northern Trust Corp acquired a new stake in Spectral AI during the fourth quarter valued at $44,000. Jane Street Group LLC purchased a new stake in shares of Spectral AI during the 2nd quarter worth about $74,000. Marshall Wace LLP acquired a new stake in shares of Spectral AI during the 2nd quarter valued at about $104,000. DNB Asset Management AS acquired a new stake in shares of Spectral AI during the 2nd quarter valued at about $107,000. Finally, XTX Topco Ltd purchased a new position in shares of Spectral AI in the 2nd quarter valued at about $123,000. Institutional investors and hedge funds own 67.08% of the company’s stock.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.